Stable NIH Funding Is Pressed By Industry/Academia Advocacy Group
Executive Summary
United for Medical Research, a year-old advocacy organization that boasts BIO as a founding member, is bringing academic and industry groups together in a long-range effort to end the boom or bust funding cycles experienced by the National Institutes of Health
You may also be interested in...
NIH Translational Research Consortium Mulls How Best To Leverage Agency's Stake In Industry, Academia, Government Relationships
"We all have different carrots and different challenges, but we also have a great deal in common, including the goal to provide improved treatments and preventions for the public," says NCRR Director Alving.
NIH Public/Private Partnerships And Health Care Reform High On Director Collins' Agenda
Industry collaborations are crucial in bringing the "discoveries that are bursting around us" to bear on development of diagnostics, preventive strategies and therapeutics, Collins says; NIH will brainstorm with economists on the cost-effectiveness of medical research.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011